Biotechnology Editor’s letter: The precision medicine issue Precision medicine has led to incredibly effective treatments for cancer and inherited disease. But not everyone gets treated. by Gideon Lichfield 2018-10-23T05:00:00-04:00
Tech Policy Why the pessimists are winning, for now The editor’s letter in the 2018 politics issue of MIT Technology Review. by Gideon Lichfield 2018-08-22T07:00:00-04:00
Biotechnology Gene Editing Could Rewrite the GMO Debate CRISPR and Talen are giving plant scientists a fast and cheap new way to create genetically modified foods. by David Rotman 2017-12-19T00:00:00-05:00
Artificial Intelligence The AI Issue Despite the worries, AI is still in its infancy. Here’s what we really need to focus on. by Brian Bergstein 2017-10-24T00:05:00-04:00
Business Impact The Thinking Behind the 10 Breakthrough Technologies Here’s what we look for, and what we hope to avoid. by Jason Pontin 2017-02-22T07:00:00-05:00
Tech Policy Closing the Digital Divide Isn’t Easy—But We Have to Try The poorest people, who might benefit most from Internet access, are often the least likely to have it. by Jason Pontin 2016-12-20T00:00:00-05:00
From the Editor MIT Technology Review Looks Different What’s changed and why? by Jason Pontin 2012-10-24T17:00:00-04:00